Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Myeloma · Hypogammaglobulinemia · Hypogammaglobulinemia, Acquired

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Zainab Shahid, MBBS) · 212-639-6483
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Zainab Shahnid, MBBS) · 212-639-6483
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Zainab Shahid, MBBS) · 212-639-6483
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity), Commack, New York, United States

    Contact: Study coordinator (Zainab Shahid, MBBS) · 212-639-6483
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Zainab Shahid, MBBS) · 212-639-6483
  • Mount Sinai Hospital, New York, New York, United States

    Contact: Study coordinator (Cesar Rodriguez, MD) · 212-241-7873
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Zainab Shahid, MBBS) · 212-639-6483
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Zainab Shahid, MBBS) · 212-639-6483
Study leads
  • Zainab Shahid, MBBS

    Principal Investigator

    Memorial Sloan Kettering Cancer Center